Pacific Biosciences Of California | PACB - Gross Profit On Sales

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $10M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
Agilent USD 990M 102M Sep/2025
Bruker USD 449.2M 69.8M Dec/2025
Danaher USD 3.97B 443M Dec/2025
General Electric Aerospace USD 3.8B 118M Dec/2025
Illumina USD 759M 26M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Pacific Biosciences Of California USD 10M 4.07M Sep/2024
Quidel USD 274.8M 1.01B Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Standard Biotools USD 9.48M 1.15M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Waters USD 557.42M 97.44M Dec/2025